Pathology and Laboratory Medicine

Dr. Glenn Palomaki was named Associate Editor for the Journal of Medical Screening.

The VALUE (VAlidation of a Lower cost aneUploidy screen) study is a three year project to provide an external evaluation of a reliable, yet low cost and easy to use cell free (cf)DNA prenatal screening test for Down syndrome in the late first and early second trimester.